Effect of fixed growth modification correctors to treat mild to moderate misaligned bite (malocclusion) in adolescents
Not Applicable
- Conditions
- Oral HealthClass II malocclusion
- Registration Number
- ISRCTN57079737
- Lead Sponsor
- niversity of Alberta
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Ongoing
- Sex
- All
- Target Recruitment
- 59
Inclusion Criteria
1. Females aged 10-13 years old and males aged 10-14 years old, with first premolars and first permanent molars, fully erupted
2. Class II molar relationship or at least ½ cusp on both sides
3. Dental crowding = 6mm
4. Overbite = 1mm
Exclusion Criteria
1. Patients with missing/unerupted permanent first premolars and molars
2. Gingival recession (below CEJ)
3. TMJ trauma syndromes
4. History of Class II corrective orthodontics
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Evaluating maxillofacial, dentoalveolar bone remodeling, and tooth position changes associated with FCC treatment using fused MRI-CBCT images and fused CBCT-CBCT<br>2. Evaluate TMJ disc remodeling and disc-condyle relationship changes associated with FCC treatment using Fused MRI-CBCT images.<br>3. Evaluate TMJ clinical function changes associated with FCC treatment using a scoring scale to detect the severity of any dysfunction. <br><br>The dental assessments will be conducted at all time points, whereas the TMJ assessments will be conducted at T1, T2, T3 & T4.<br><br>Timepoints:<br>T1: Baseline records for all groups at the enrolment date<br>T2: 12 months after T1 (before full bonded orthodontic treatment for all groups)<br>T3: 18 – 30 months after T2 (after debonding of orthodontic treatment for all groups)<br>T4: 24 months after T3
- Secondary Outcome Measures
Name Time Method 1. Evaluating gingival attachment and periodontal condition changes associated with FCC treatment, using Clinical assessment at all 4 assessment times (T1, T2, T3, T4) <br>2. Evaluate the FCCs impact on participants' quality of life associated with FCC treatment using a self-reported Questionnaire:<br>Patients will be provided with a questionnaire to evaluate their overall experience during the FCC treatment. Patients will be asked to answer this survey at all 4 assessment times (T1, T2, T3, T4).